Weekly Insights & Analysis
Consumer Private Placement and M&A Transactions Review Week Ending Jan 28, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Ohalo Genetics: The company raised $40 million of venture funding from undisclosed investors on January 25, 2024. The company is a developer of a plant genetic technology. Protealis: The...
Healthcare Private Placement and M&A Transactions Review Week Ending Jan 28, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Synnovation Therapeutics: The company raised $102 million of Series A venture funding in a deal led by Third Rock Ventures on January 24, 2024, putting the company's pre-money valuation at...
Consumer Private Placement and M&A Transactions Review Week Ending Jan 21, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Bloom Nutrition: The company received $90 million of development capital from Nutrabolt, Amberstone and Mr. Clayton Christopher on January 17, 2024. The company is a producer and seller of...
Healthcare Private Placement and M&A Transactions Review Week Ending Jan 21, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions ClevelandDx: The company raised $75 million through a combination of debt, Series E1 and Series E2 venture funding in a deal led by Novo Holdings on January 17, 2024, putting the company's...
Technology Private Placement and M&A Transactions Review Week Ending Jan 21, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Build A Rocket Boy: The company received $110 million of development capital led by RedBird Capital Partners and from NetEase, Endeavor, Alignment Growth, Galaxy Interactive and Woodline...
A weekly digest of strategy and finance perspectives in charts, together with a review of M&A and private placement transactions by industry sector.